To assess whether PSAP trafficking is affected by GRN mutations in patients with FTLD-TDP, we stained PSAP and saposins in the orbitofrontal cortex of controls, and in patients with FTLD due to GRN mutations (FTLD-GRN), or AD. This evidence concerns the gene PSAP and Alzheimer disease.